United States · 
Who invested in Decibel Therapeutics?
Decibel Therapeutics's investors include SR One, Third Rock Ventures, Bessemer Venture Partners, Google Ventures and BlackRock, and 9 more on record.
20162017201820192020
$52MSeries A$55MSeries C$82MSeries D
United States · Series D startup
Who invested in Decibel Therapeutics
Funding summaryUpdated 26 Oct 2026
$189Mraised across 3 rounds since 2015, from 3 sources
$52MSeries A$55MSeries C$82MSeries D
- Latest round
- Series D, $82MNov 2020
- Step-upi
- 1.5×
- Investors
- 14
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A, $52M Oct 2015
- Biggest round
- $82M Series D · Nov 2020
- Usual gap between rounds
- 2.7 years the median of 2
The rounds
- Nov 2020Series D$82M4 new1 returning
Source recordedSEC filing: $55M sold, first sale Nov 2020
- Jun 2018Series C$55M7 new2 returning
Google Ventures
SR One
Third Rock Ventures- Bessemer
S-Cubed Capital- Foresite
- Schroder Adveq
- Regeneron Pharmaceuticals
- Longevity
Reported by FinSMEs
- Oct 2015Series A$52M3 new
From a historical funding recordSEC filing: $8.0M sold, first sale Oct 2015
Founders and team
From Decibel Therapeutics's own website and the SEC filings it signed: 17 on the team.
- Chris FenimoreExecutive Vice President, Finance and Chief Financial Officer
- Ryan SteinbergerExecutive Vice President, Chief Digital & Technology Officer
- Anthony PankauSenior Vice President, Manufacturing Operations
- Benjamin YocumSenior Vice President, Manufacturing Operations
- Brook JenningsSenior Vice President, Global Immunology Commercial Business Unit
- Christine ChildroseSenior Vice President, Human Resources and HR Operations
- Don SawyerSenior Vice President, Global Market Access
- Evgeniya MakarovaSenior Vice President, IOPS Finance & Business Operations
- George PothSenior Vice President, Real Estate & Facilities Management
- Justin HolkoSenior Vice President, Global Oncology/Hematology Commercial Business Unit
- Kevin ClarkSenior Vice President, Global Ophthalmology Commercial Business Unit
- Matthew EverettSenior Vice President, Global Procurement
- Nouhad HusseiniSenior Vice President, Business Development
- Rajesh AhujaSenior Vice President, Quality Assurance and Operations
- Tikiri DissanayakeSenior Vice President, IOPS Technical Operations
- Elisabeth LeidermanExecutive Officeri
- Laurence ReidExecutive Officer, Directori
On the board, as filediAnthony A. PhilippakisChristine A. PoonNeil A. ExterPeter A. Thompson
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
BessemerVC firm1round
ForesiteVC firm1round
Schroder AdveqVC firm1round
Regeneron PharmaceuticalsVC firm1round
Longevityno record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Decibel Therapeutics
How much has Decibel Therapeutics raised?
Decibel Therapeutics has raised $189M across 3 rounds since 2015.
When did Decibel Therapeutics last raise?
Decibel Therapeutics's most recent round was a Series D of $82M in Nov 2020.
What was Decibel Therapeutics's biggest round?
Its most recent round, $82M in Nov 2020, is also its largest on record.
Who backed Decibel Therapeutics first?
Decibel Therapeutics's first round on record, in Oct 2015, was backed by SR One, Third Rock Ventures and GlaxoSmithKline.
What stage is Decibel Therapeutics at?
Decibel Therapeutics's latest named round is a Series D, in Nov 2020.
Where is Decibel Therapeutics based?
Decibel Therapeutics is based in the United States.
Companies like Decibel Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.